nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolmitriptan—migraine—Prednisone—Crohn's disease	0.872	1	CpDpCtD
Zolmitriptan—Colitis—Azathioprine—Crohn's disease	0.000795	0.00699	CcSEcCtD
Zolmitriptan—Neck pain—Mesalazine—Crohn's disease	0.000764	0.00672	CcSEcCtD
Zolmitriptan—Stomatitis—Mercaptopurine—Crohn's disease	0.000758	0.00667	CcSEcCtD
Zolmitriptan—Phosphatase alkaline increased—Mesalazine—Crohn's disease	0.000755	0.00664	CcSEcCtD
Zolmitriptan—Vaginal inflammation—Mesalazine—Crohn's disease	0.000755	0.00664	CcSEcCtD
Zolmitriptan—Neoplasm—Azathioprine—Crohn's disease	0.000749	0.00659	CcSEcCtD
Zolmitriptan—Abnormal dreams—Mesalazine—Crohn's disease	0.000746	0.00656	CcSEcCtD
Zolmitriptan—Eructation—Mesalazine—Crohn's disease	0.000741	0.00652	CcSEcCtD
Zolmitriptan—Melaena—Mesalazine—Crohn's disease	0.000737	0.00648	CcSEcCtD
Zolmitriptan—Cystitis noninfective—Mesalazine—Crohn's disease	0.000737	0.00648	CcSEcCtD
Zolmitriptan—Cystitis—Mesalazine—Crohn's disease	0.000729	0.00641	CcSEcCtD
Zolmitriptan—Colitis—Mesalazine—Crohn's disease	0.000724	0.00637	CcSEcCtD
Zolmitriptan—Vaginal infection—Mesalazine—Crohn's disease	0.000712	0.00626	CcSEcCtD
Zolmitriptan—Osteoporosis—Prednisone—Crohn's disease	0.000712	0.00626	CcSEcCtD
Zolmitriptan—Neuropathy—Mesalazine—Crohn's disease	0.000708	0.00623	CcSEcCtD
Zolmitriptan—Dry eye—Mesalazine—Crohn's disease	0.000697	0.00613	CcSEcCtD
Zolmitriptan—Cramps of lower extremities—Mesalazine—Crohn's disease	0.000693	0.0061	CcSEcCtD
Zolmitriptan—Ecchymosis—Mesalazine—Crohn's disease	0.000682	0.006	CcSEcCtD
Zolmitriptan—Bladder pain—Mesalazine—Crohn's disease	0.000682	0.006	CcSEcCtD
Zolmitriptan—Hypertonia—Mesalazine—Crohn's disease	0.000661	0.00582	CcSEcCtD
Zolmitriptan—Ear pain—Mesalazine—Crohn's disease	0.000642	0.00564	CcSEcCtD
Zolmitriptan—Lymphadenopathy—Mesalazine—Crohn's disease	0.000642	0.00564	CcSEcCtD
Zolmitriptan—Melatonin—MPO—Crohn's disease	0.000633	1	CrCbGaD
Zolmitriptan—Immune system disorder—Mercaptopurine—Crohn's disease	0.000631	0.00555	CcSEcCtD
Zolmitriptan—Blood alkaline phosphatase increased—Mesalazine—Crohn's disease	0.00063	0.00554	CcSEcCtD
Zolmitriptan—Photosensitivity—Mesalazine—Crohn's disease	0.000624	0.00549	CcSEcCtD
Zolmitriptan—Gastroenteritis—Mesalazine—Crohn's disease	0.000618	0.00543	CcSEcCtD
Zolmitriptan—Eczema—Mesalazine—Crohn's disease	0.000609	0.00536	CcSEcCtD
Zolmitriptan—Eye pain—Mesalazine—Crohn's disease	0.000607	0.00533	CcSEcCtD
Zolmitriptan—Increased appetite—Mesalazine—Crohn's disease	0.000583	0.00513	CcSEcCtD
Zolmitriptan—Atrial fibrillation—Mesalazine—Crohn's disease	0.000578	0.00508	CcSEcCtD
Zolmitriptan—Thirst—Mesalazine—Crohn's disease	0.000575	0.00506	CcSEcCtD
Zolmitriptan—Arthritis—Mesalazine—Crohn's disease	0.000564	0.00496	CcSEcCtD
Zolmitriptan—Mania—Prednisone—Crohn's disease	0.000549	0.00483	CcSEcCtD
Zolmitriptan—Osteoarthritis—Mesalazine—Crohn's disease	0.000548	0.00482	CcSEcCtD
Zolmitriptan—Leukopenia—Mercaptopurine—Crohn's disease	0.000544	0.00478	CcSEcCtD
Zolmitriptan—Affect lability—Mesalazine—Crohn's disease	0.000539	0.00474	CcSEcCtD
Zolmitriptan—Migraine—Mesalazine—Crohn's disease	0.000539	0.00474	CcSEcCtD
Zolmitriptan—Face oedema—Mesalazine—Crohn's disease	0.000529	0.00465	CcSEcCtD
Zolmitriptan—Mood swings—Mesalazine—Crohn's disease	0.000519	0.00456	CcSEcCtD
Zolmitriptan—Arthralgia—Mercaptopurine—Crohn's disease	0.000517	0.00455	CcSEcCtD
Zolmitriptan—Pancreatitis—Azathioprine—Crohn's disease	0.00051	0.00448	CcSEcCtD
Zolmitriptan—Necrosis—Prednisone—Crohn's disease	0.000509	0.00447	CcSEcCtD
Zolmitriptan—Orthostatic hypotension—Mesalazine—Crohn's disease	0.0005	0.0044	CcSEcCtD
Zolmitriptan—Oedema—Mercaptopurine—Crohn's disease	0.000496	0.00436	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.000486	0.00427	CcSEcCtD
Zolmitriptan—Gastritis—Mesalazine—Crohn's disease	0.000485	0.00426	CcSEcCtD
Zolmitriptan—Skin disorder—Mercaptopurine—Crohn's disease	0.000482	0.00424	CcSEcCtD
Zolmitriptan—Influenza—Mesalazine—Crohn's disease	0.000473	0.00416	CcSEcCtD
Zolmitriptan—Dysphagia—Mesalazine—Crohn's disease	0.000473	0.00416	CcSEcCtD
Zolmitriptan—Anorexia—Mercaptopurine—Crohn's disease	0.000473	0.00416	CcSEcCtD
Zolmitriptan—Eosinophilia—Mesalazine—Crohn's disease	0.000469	0.00412	CcSEcCtD
Zolmitriptan—Pneumonia—Azathioprine—Crohn's disease	0.000466	0.0041	CcSEcCtD
Zolmitriptan—Bronchospasm—Mesalazine—Crohn's disease	0.000466	0.00409	CcSEcCtD
Zolmitriptan—Pancreatitis—Mesalazine—Crohn's disease	0.000464	0.00408	CcSEcCtD
Zolmitriptan—Angina pectoris—Mesalazine—Crohn's disease	0.000461	0.00405	CcSEcCtD
Zolmitriptan—Bronchitis—Mesalazine—Crohn's disease	0.000455	0.004	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.000452	0.00397	CcSEcCtD
Zolmitriptan—Arthropathy—Prednisone—Crohn's disease	0.000439	0.00386	CcSEcCtD
Zolmitriptan—Pollakiuria—Mesalazine—Crohn's disease	0.000437	0.00385	CcSEcCtD
Zolmitriptan—Photosensitivity reaction—Mesalazine—Crohn's disease	0.000432	0.0038	CcSEcCtD
Zolmitriptan—Decreased appetite—Mercaptopurine—Crohn's disease	0.000431	0.00379	CcSEcCtD
Zolmitriptan—Weight increased—Mesalazine—Crohn's disease	0.000431	0.00379	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000428	0.00377	CcSEcCtD
Zolmitriptan—Pneumonia—Mesalazine—Crohn's disease	0.000425	0.00373	CcSEcCtD
Zolmitriptan—Ulcer—Prednisone—Crohn's disease	0.000422	0.00371	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Mesalazine—Crohn's disease	0.000414	0.00364	CcSEcCtD
Zolmitriptan—Stomatitis—Mesalazine—Crohn's disease	0.000411	0.00362	CcSEcCtD
Zolmitriptan—Jaundice—Mesalazine—Crohn's disease	0.000411	0.00362	CcSEcCtD
Zolmitriptan—Conjunctivitis—Mesalazine—Crohn's disease	0.00041	0.00361	CcSEcCtD
Zolmitriptan—Urinary tract infection—Mesalazine—Crohn's disease	0.00041	0.00361	CcSEcCtD
Zolmitriptan—Sweating—Mesalazine—Crohn's disease	0.000405	0.00356	CcSEcCtD
Zolmitriptan—Haematuria—Mesalazine—Crohn's disease	0.000402	0.00354	CcSEcCtD
Zolmitriptan—Hiccups—Prednisone—Crohn's disease	0.000399	0.00351	CcSEcCtD
Zolmitriptan—Epistaxis—Mesalazine—Crohn's disease	0.000398	0.0035	CcSEcCtD
Zolmitriptan—Sinusitis—Mesalazine—Crohn's disease	0.000396	0.00348	CcSEcCtD
Zolmitriptan—Body temperature increased—Mercaptopurine—Crohn's disease	0.000392	0.00345	CcSEcCtD
Zolmitriptan—Rhinitis—Mesalazine—Crohn's disease	0.00038	0.00334	CcSEcCtD
Zolmitriptan—Pharyngitis—Mesalazine—Crohn's disease	0.000376	0.00331	CcSEcCtD
Zolmitriptan—Immune system disorder—Azathioprine—Crohn's disease	0.000376	0.0033	CcSEcCtD
Zolmitriptan—Neuropathy—Prednisone—Crohn's disease	0.000375	0.0033	CcSEcCtD
Zolmitriptan—Urinary tract disorder—Mesalazine—Crohn's disease	0.000374	0.00329	CcSEcCtD
Zolmitriptan—Oedema peripheral—Mesalazine—Crohn's disease	0.000373	0.00328	CcSEcCtD
Zolmitriptan—Chills—Azathioprine—Crohn's disease	0.000373	0.00328	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Mesalazine—Crohn's disease	0.000372	0.00327	CcSEcCtD
Zolmitriptan—Arrhythmia—Azathioprine—Crohn's disease	0.000372	0.00327	CcSEcCtD
Zolmitriptan—Urethral disorder—Mesalazine—Crohn's disease	0.000371	0.00327	CcSEcCtD
Zolmitriptan—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000365	0.00321	CcSEcCtD
Zolmitriptan—Oesophagitis—Prednisone—Crohn's disease	0.000365	0.00321	CcSEcCtD
Zolmitriptan—Ecchymosis—Prednisone—Crohn's disease	0.000361	0.00317	CcSEcCtD
Zolmitriptan—Pulmonary oedema—Prednisone—Crohn's disease	0.000355	0.00312	CcSEcCtD
Zolmitriptan—Tinnitus—Mesalazine—Crohn's disease	0.000353	0.00311	CcSEcCtD
Zolmitriptan—Cardiac disorder—Mesalazine—Crohn's disease	0.000352	0.00309	CcSEcCtD
Zolmitriptan—Hyperkinesia—Prednisone—Crohn's disease	0.000348	0.00306	CcSEcCtD
Zolmitriptan—Angiopathy—Mesalazine—Crohn's disease	0.000344	0.00302	CcSEcCtD
Zolmitriptan—Euphoric mood—Prednisone—Crohn's disease	0.000343	0.00302	CcSEcCtD
Zolmitriptan—Immune system disorder—Mesalazine—Crohn's disease	0.000342	0.00301	CcSEcCtD
Zolmitriptan—Chills—Mesalazine—Crohn's disease	0.00034	0.00299	CcSEcCtD
Zolmitriptan—Diarrhoea—Mercaptopurine—Crohn's disease	0.000339	0.00298	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Azathioprine—Crohn's disease	0.000336	0.00295	CcSEcCtD
Zolmitriptan—Thrombophlebitis—Prednisone—Crohn's disease	0.000335	0.00294	CcSEcCtD
Zolmitriptan—Erythema—Mesalazine—Crohn's disease	0.00033	0.0029	CcSEcCtD
Zolmitriptan—Malaise—Azathioprine—Crohn's disease	0.000327	0.00287	CcSEcCtD
Zolmitriptan—Leukopenia—Azathioprine—Crohn's disease	0.000324	0.00285	CcSEcCtD
Zolmitriptan—Tension—Mesalazine—Crohn's disease	0.000324	0.00285	CcSEcCtD
Zolmitriptan—Dysgeusia—Mesalazine—Crohn's disease	0.000323	0.00284	CcSEcCtD
Zolmitriptan—Nervousness—Mesalazine—Crohn's disease	0.00032	0.00282	CcSEcCtD
Zolmitriptan—Back pain—Mesalazine—Crohn's disease	0.000319	0.00281	CcSEcCtD
Zolmitriptan—Muscle spasms—Mesalazine—Crohn's disease	0.000317	0.00279	CcSEcCtD
Zolmitriptan—Vomiting—Mercaptopurine—Crohn's disease	0.000315	0.00277	CcSEcCtD
Zolmitriptan—Rash—Mercaptopurine—Crohn's disease	0.000313	0.00275	CcSEcCtD
Zolmitriptan—Dermatitis—Mercaptopurine—Crohn's disease	0.000312	0.00275	CcSEcCtD
Zolmitriptan—Tremor—Mesalazine—Crohn's disease	0.000309	0.00272	CcSEcCtD
Zolmitriptan—Amnesia—Prednisone—Crohn's disease	0.000308	0.00271	CcSEcCtD
Zolmitriptan—Increased appetite—Prednisone—Crohn's disease	0.000308	0.00271	CcSEcCtD
Zolmitriptan—Arthralgia—Azathioprine—Crohn's disease	0.000308	0.00271	CcSEcCtD
Zolmitriptan—Myalgia—Azathioprine—Crohn's disease	0.000308	0.00271	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Mesalazine—Crohn's disease	0.000306	0.00269	CcSEcCtD
Zolmitriptan—Discomfort—Azathioprine—Crohn's disease	0.000305	0.00268	CcSEcCtD
Zolmitriptan—Angioedema—Mesalazine—Crohn's disease	0.000301	0.00265	CcSEcCtD
Zolmitriptan—Malaise—Mesalazine—Crohn's disease	0.000297	0.00262	CcSEcCtD
Zolmitriptan—Vertigo—Mesalazine—Crohn's disease	0.000296	0.00261	CcSEcCtD
Zolmitriptan—Syncope—Mesalazine—Crohn's disease	0.000296	0.0026	CcSEcCtD
Zolmitriptan—Leukopenia—Mesalazine—Crohn's disease	0.000295	0.0026	CcSEcCtD
Zolmitriptan—Nausea—Mercaptopurine—Crohn's disease	0.000295	0.00259	CcSEcCtD
Zolmitriptan—Infection—Azathioprine—Crohn's disease	0.000294	0.00258	CcSEcCtD
Zolmitriptan—Palpitations—Mesalazine—Crohn's disease	0.000291	0.00256	CcSEcCtD
Zolmitriptan—Loss of consciousness—Mesalazine—Crohn's disease	0.00029	0.00255	CcSEcCtD
Zolmitriptan—Osteoarthritis—Prednisone—Crohn's disease	0.00029	0.00255	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Azathioprine—Crohn's disease	0.000289	0.00254	CcSEcCtD
Zolmitriptan—Cough—Mesalazine—Crohn's disease	0.000288	0.00253	CcSEcCtD
Zolmitriptan—Skin disorder—Azathioprine—Crohn's disease	0.000287	0.00252	CcSEcCtD
Zolmitriptan—Affect lability—Prednisone—Crohn's disease	0.000285	0.00251	CcSEcCtD
Zolmitriptan—Hypertension—Mesalazine—Crohn's disease	0.000285	0.0025	CcSEcCtD
Zolmitriptan—Psychotic disorder—Prednisone—Crohn's disease	0.000283	0.00249	CcSEcCtD
Zolmitriptan—Arthralgia—Mesalazine—Crohn's disease	0.000281	0.00247	CcSEcCtD
Zolmitriptan—Chest pain—Mesalazine—Crohn's disease	0.000281	0.00247	CcSEcCtD
Zolmitriptan—Myalgia—Mesalazine—Crohn's disease	0.000281	0.00247	CcSEcCtD
Zolmitriptan—Anxiety—Mesalazine—Crohn's disease	0.00028	0.00246	CcSEcCtD
Zolmitriptan—Face oedema—Prednisone—Crohn's disease	0.00028	0.00246	CcSEcCtD
Zolmitriptan—Discomfort—Mesalazine—Crohn's disease	0.000277	0.00244	CcSEcCtD
Zolmitriptan—Irritability—Prednisone—Crohn's disease	0.000277	0.00243	CcSEcCtD
Zolmitriptan—Dry mouth—Mesalazine—Crohn's disease	0.000275	0.00241	CcSEcCtD
Zolmitriptan—Mood swings—Prednisone—Crohn's disease	0.000275	0.00241	CcSEcCtD
Zolmitriptan—Confusional state—Mesalazine—Crohn's disease	0.000271	0.00239	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.000269	0.00237	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Mesalazine—Crohn's disease	0.000269	0.00237	CcSEcCtD
Zolmitriptan—Oedema—Mesalazine—Crohn's disease	0.000269	0.00237	CcSEcCtD
Zolmitriptan—Infection—Mesalazine—Crohn's disease	0.000267	0.00235	CcSEcCtD
Zolmitriptan—Shock—Mesalazine—Crohn's disease	0.000265	0.00233	CcSEcCtD
Zolmitriptan—Nervous system disorder—Mesalazine—Crohn's disease	0.000264	0.00232	CcSEcCtD
Zolmitriptan—Thrombocytopenia—Mesalazine—Crohn's disease	0.000264	0.00232	CcSEcCtD
Zolmitriptan—Tachycardia—Mesalazine—Crohn's disease	0.000263	0.00231	CcSEcCtD
Zolmitriptan—Skin disorder—Mesalazine—Crohn's disease	0.000261	0.0023	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Mesalazine—Crohn's disease	0.00026	0.00229	CcSEcCtD
Zolmitriptan—Anorexia—Mesalazine—Crohn's disease	0.000257	0.00226	CcSEcCtD
Zolmitriptan—Muscular weakness—Prednisone—Crohn's disease	0.000256	0.00225	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000255	0.00224	CcSEcCtD
Zolmitriptan—Pancreatitis—Prednisone—Crohn's disease	0.000246	0.00216	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000245	0.00216	CcSEcCtD
Zolmitriptan—Feeling abnormal—Azathioprine—Crohn's disease	0.000244	0.00214	CcSEcCtD
Zolmitriptan—Insomnia—Mesalazine—Crohn's disease	0.000243	0.00214	CcSEcCtD
Zolmitriptan—Paraesthesia—Mesalazine—Crohn's disease	0.000242	0.00213	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000242	0.00213	CcSEcCtD
Zolmitriptan—Dyspnoea—Mesalazine—Crohn's disease	0.00024	0.00211	CcSEcCtD
Zolmitriptan—Somnolence—Mesalazine—Crohn's disease	0.000239	0.0021	CcSEcCtD
Zolmitriptan—Dyspepsia—Mesalazine—Crohn's disease	0.000237	0.00208	CcSEcCtD
Zolmitriptan—Decreased appetite—Mesalazine—Crohn's disease	0.000234	0.00206	CcSEcCtD
Zolmitriptan—Body temperature increased—Azathioprine—Crohn's disease	0.000234	0.00205	CcSEcCtD
Zolmitriptan—Abdominal pain—Azathioprine—Crohn's disease	0.000234	0.00205	CcSEcCtD
Zolmitriptan—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000232	0.00204	CcSEcCtD
Zolmitriptan—Pain—Mesalazine—Crohn's disease	0.00023	0.00202	CcSEcCtD
Zolmitriptan—Constipation—Mesalazine—Crohn's disease	0.00023	0.00202	CcSEcCtD
Zolmitriptan—Weight increased—Prednisone—Crohn's disease	0.000228	0.002	CcSEcCtD
Zolmitriptan—Hyperglycaemia—Prednisone—Crohn's disease	0.000226	0.00199	CcSEcCtD
Zolmitriptan—Feeling abnormal—Mesalazine—Crohn's disease	0.000222	0.00195	CcSEcCtD
Zolmitriptan—Acute coronary syndrome—Prednisone—Crohn's disease	0.00022	0.00194	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00022	0.00194	CcSEcCtD
Zolmitriptan—Myocardial infarction—Prednisone—Crohn's disease	0.000219	0.00192	CcSEcCtD
Zolmitriptan—Neuropathy peripheral—Prednisone—Crohn's disease	0.000219	0.00192	CcSEcCtD
Zolmitriptan—Hypersensitivity—Azathioprine—Crohn's disease	0.000218	0.00191	CcSEcCtD
Zolmitriptan—Urticaria—Mesalazine—Crohn's disease	0.000214	0.00188	CcSEcCtD
Zolmitriptan—Body temperature increased—Mesalazine—Crohn's disease	0.000213	0.00187	CcSEcCtD
Zolmitriptan—Abdominal pain—Mesalazine—Crohn's disease	0.000213	0.00187	CcSEcCtD
Zolmitriptan—Bradycardia—Prednisone—Crohn's disease	0.000204	0.00179	CcSEcCtD
Zolmitriptan—Diarrhoea—Azathioprine—Crohn's disease	0.000202	0.00178	CcSEcCtD
Zolmitriptan—Hallucination—Prednisone—Crohn's disease	0.000199	0.00175	CcSEcCtD
Zolmitriptan—Hypersensitivity—Mesalazine—Crohn's disease	0.000198	0.00174	CcSEcCtD
Zolmitriptan—Connective tissue disorder—Prednisone—Crohn's disease	0.000197	0.00173	CcSEcCtD
Zolmitriptan—Dizziness—Azathioprine—Crohn's disease	0.000195	0.00172	CcSEcCtD
Zolmitriptan—Asthenia—Mesalazine—Crohn's disease	0.000193	0.0017	CcSEcCtD
Zolmitriptan—Pruritus—Mesalazine—Crohn's disease	0.00019	0.00167	CcSEcCtD
Zolmitriptan—Vomiting—Azathioprine—Crohn's disease	0.000188	0.00165	CcSEcCtD
Zolmitriptan—Rash—Azathioprine—Crohn's disease	0.000186	0.00164	CcSEcCtD
Zolmitriptan—Dermatitis—Azathioprine—Crohn's disease	0.000186	0.00164	CcSEcCtD
Zolmitriptan—Headache—Azathioprine—Crohn's disease	0.000185	0.00163	CcSEcCtD
Zolmitriptan—Diarrhoea—Mesalazine—Crohn's disease	0.000184	0.00162	CcSEcCtD
Zolmitriptan—Angiopathy—Prednisone—Crohn's disease	0.000182	0.0016	CcSEcCtD
Zolmitriptan—Immune system disorder—Prednisone—Crohn's disease	0.000181	0.00159	CcSEcCtD
Zolmitriptan—Arrhythmia—Prednisone—Crohn's disease	0.000179	0.00157	CcSEcCtD
Zolmitriptan—Dizziness—Mesalazine—Crohn's disease	0.000178	0.00157	CcSEcCtD
Zolmitriptan—Nausea—Azathioprine—Crohn's disease	0.000176	0.00154	CcSEcCtD
Zolmitriptan—Erythema—Prednisone—Crohn's disease	0.000175	0.00153	CcSEcCtD
Zolmitriptan—Vomiting—Mesalazine—Crohn's disease	0.000171	0.00151	CcSEcCtD
Zolmitriptan—Rash—Mesalazine—Crohn's disease	0.00017	0.00149	CcSEcCtD
Zolmitriptan—Dermatitis—Mesalazine—Crohn's disease	0.00017	0.00149	CcSEcCtD
Zolmitriptan—Headache—Mesalazine—Crohn's disease	0.000169	0.00148	CcSEcCtD
Zolmitriptan—Ill-defined disorder—Prednisone—Crohn's disease	0.000162	0.00142	CcSEcCtD
Zolmitriptan—Agitation—Prednisone—Crohn's disease	0.00016	0.00141	CcSEcCtD
Zolmitriptan—Nausea—Mesalazine—Crohn's disease	0.00016	0.00141	CcSEcCtD
Zolmitriptan—Angioedema—Prednisone—Crohn's disease	0.000159	0.0014	CcSEcCtD
Zolmitriptan—Malaise—Prednisone—Crohn's disease	0.000157	0.00138	CcSEcCtD
Zolmitriptan—Vertigo—Prednisone—Crohn's disease	0.000157	0.00138	CcSEcCtD
Zolmitriptan—Syncope—Prednisone—Crohn's disease	0.000156	0.00138	CcSEcCtD
Zolmitriptan—Loss of consciousness—Prednisone—Crohn's disease	0.000153	0.00135	CcSEcCtD
Zolmitriptan—Convulsion—Prednisone—Crohn's disease	0.000151	0.00133	CcSEcCtD
Zolmitriptan—Hypertension—Prednisone—Crohn's disease	0.000151	0.00132	CcSEcCtD
Zolmitriptan—Arthralgia—Prednisone—Crohn's disease	0.000149	0.00131	CcSEcCtD
Zolmitriptan—Myalgia—Prednisone—Crohn's disease	0.000149	0.00131	CcSEcCtD
Zolmitriptan—Anxiety—Prednisone—Crohn's disease	0.000148	0.0013	CcSEcCtD
Zolmitriptan—Discomfort—Prednisone—Crohn's disease	0.000147	0.00129	CcSEcCtD
Zolmitriptan—Oedema—Prednisone—Crohn's disease	0.000142	0.00125	CcSEcCtD
Zolmitriptan—Anaphylactic shock—Prednisone—Crohn's disease	0.000142	0.00125	CcSEcCtD
Zolmitriptan—Infection—Prednisone—Crohn's disease	0.000141	0.00124	CcSEcCtD
Zolmitriptan—Shock—Prednisone—Crohn's disease	0.00014	0.00123	CcSEcCtD
Zolmitriptan—Nervous system disorder—Prednisone—Crohn's disease	0.00014	0.00123	CcSEcCtD
Zolmitriptan—Tachycardia—Prednisone—Crohn's disease	0.000139	0.00122	CcSEcCtD
Zolmitriptan—Skin disorder—Prednisone—Crohn's disease	0.000138	0.00122	CcSEcCtD
Zolmitriptan—Hyperhidrosis—Prednisone—Crohn's disease	0.000138	0.00121	CcSEcCtD
Zolmitriptan—Anorexia—Prednisone—Crohn's disease	0.000136	0.00119	CcSEcCtD
Zolmitriptan—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.00013	0.00114	CcSEcCtD
Zolmitriptan—Insomnia—Prednisone—Crohn's disease	0.000129	0.00113	CcSEcCtD
Zolmitriptan—Paraesthesia—Prednisone—Crohn's disease	0.000128	0.00112	CcSEcCtD
Zolmitriptan—Dyspepsia—Prednisone—Crohn's disease	0.000125	0.0011	CcSEcCtD
Zolmitriptan—Decreased appetite—Prednisone—Crohn's disease	0.000124	0.00109	CcSEcCtD
Zolmitriptan—Constipation—Prednisone—Crohn's disease	0.000122	0.00107	CcSEcCtD
Zolmitriptan—Feeling abnormal—Prednisone—Crohn's disease	0.000117	0.00103	CcSEcCtD
Zolmitriptan—Gastrointestinal pain—Prednisone—Crohn's disease	0.000116	0.00102	CcSEcCtD
Zolmitriptan—Urticaria—Prednisone—Crohn's disease	0.000113	0.000995	CcSEcCtD
Zolmitriptan—Abdominal pain—Prednisone—Crohn's disease	0.000113	0.00099	CcSEcCtD
Zolmitriptan—Body temperature increased—Prednisone—Crohn's disease	0.000113	0.00099	CcSEcCtD
Zolmitriptan—Hypersensitivity—Prednisone—Crohn's disease	0.000105	0.000923	CcSEcCtD
Zolmitriptan—Asthenia—Prednisone—Crohn's disease	0.000102	0.000899	CcSEcCtD
Zolmitriptan—Pruritus—Prednisone—Crohn's disease	0.000101	0.000886	CcSEcCtD
Zolmitriptan—Diarrhoea—Prednisone—Crohn's disease	9.74e-05	0.000857	CcSEcCtD
Zolmitriptan—Dizziness—Prednisone—Crohn's disease	9.42e-05	0.000828	CcSEcCtD
Zolmitriptan—Vomiting—Prednisone—Crohn's disease	9.06e-05	0.000796	CcSEcCtD
Zolmitriptan—Rash—Prednisone—Crohn's disease	8.98e-05	0.00079	CcSEcCtD
Zolmitriptan—Dermatitis—Prednisone—Crohn's disease	8.97e-05	0.000789	CcSEcCtD
Zolmitriptan—Headache—Prednisone—Crohn's disease	8.92e-05	0.000785	CcSEcCtD
Zolmitriptan—Nausea—Prednisone—Crohn's disease	8.46e-05	0.000744	CcSEcCtD
Zolmitriptan—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	7.12e-05	0.00511	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—GPR65—Crohn's disease	7.12e-05	0.00511	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—PTGER4—Crohn's disease	6.98e-05	0.00501	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	6.97e-05	0.00501	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—GPR65—Crohn's disease	6.97e-05	0.005	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	6.84e-05	0.00491	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCR9—Crohn's disease	6.77e-05	0.00486	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	6.7e-05	0.00481	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	6.66e-05	0.00478	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	6.52e-05	0.00468	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—GPR65—Crohn's disease	6.29e-05	0.00452	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CCR6—Crohn's disease	6.25e-05	0.00449	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—MLN—Crohn's disease	6.24e-05	0.00448	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CCR9—Crohn's disease	6.14e-05	0.00441	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—MLN—Crohn's disease	6.11e-05	0.00439	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL10—Crohn's disease	6.01e-05	0.00432	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—ACKR2—Crohn's disease	5.98e-05	0.00429	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	5.86e-05	0.00421	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—ACKR2—Crohn's disease	5.86e-05	0.0042	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	5.8e-05	0.00416	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	5.74e-05	0.00412	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—GPR65—Crohn's disease	5.71e-05	0.0041	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCR9—Crohn's disease	5.71e-05	0.0041	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—MLN—Crohn's disease	5.67e-05	0.00407	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—MLN—Crohn's disease	5.55e-05	0.00398	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—ACKR2—Crohn's disease	5.52e-05	0.00397	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—GPR65—Crohn's disease	5.31e-05	0.00381	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—MLN—Crohn's disease	5.24e-05	0.00376	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL10—Crohn's disease	5.11e-05	0.00367	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	5.11e-05	0.00366	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CCR6—Crohn's disease	5.07e-05	0.00364	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	4.97e-05	0.00357	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CCR6—Crohn's disease	4.97e-05	0.00357	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TAGAP—Crohn's disease	4.79e-05	0.00344	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—MLN—Crohn's disease	4.66e-05	0.00334	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CCR6—Crohn's disease	4.48e-05	0.00322	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—PTGER4—Crohn's disease	4.47e-05	0.00321	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—ACKR2—Crohn's disease	4.46e-05	0.0032	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	4.37e-05	0.00314	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—PTGER4—Crohn's disease	4.37e-05	0.00314	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCR9—Crohn's disease	4.33e-05	0.00311	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	4.24e-05	0.00304	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCR9—Crohn's disease	4.24e-05	0.00304	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—MLN—Crohn's disease	4.23e-05	0.00304	CbGpPWpGaD
Zolmitriptan—HTR1F—G alpha (i) signalling events—CXCL8—Crohn's disease	4.22e-05	0.00303	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RSPO3—Crohn's disease	4.19e-05	0.00301	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CCR6—Crohn's disease	4.07e-05	0.00292	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—GPR65—Crohn's disease	4.02e-05	0.00289	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SEL1L—Crohn's disease	3.97e-05	0.00285	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—PTGER4—Crohn's disease	3.95e-05	0.00283	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—GPR65—Crohn's disease	3.94e-05	0.00283	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCR9—Crohn's disease	3.93e-05	0.00282	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCR9—Crohn's disease	3.85e-05	0.00276	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CCR6—Crohn's disease	3.78e-05	0.00272	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—GPR65—Crohn's disease	3.65e-05	0.00262	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCR9—Crohn's disease	3.63e-05	0.00261	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—PTGER4—Crohn's disease	3.58e-05	0.00257	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—GPR65—Crohn's disease	3.58e-05	0.00257	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—ACKR2—Crohn's disease	3.53e-05	0.00254	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	3.46e-05	0.00249	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—ACKR2—Crohn's disease	3.46e-05	0.00248	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—GPR65—Crohn's disease	3.37e-05	0.00242	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—IL3—Crohn's disease	3.36e-05	0.00241	CbGpPWpGaD
Zolmitriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	3.36e-05	0.00241	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—MLN—Crohn's disease	3.35e-05	0.0024	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—PTGER4—Crohn's disease	3.33e-05	0.00239	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	3.32e-05	0.00238	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	3.29e-05	0.00236	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—MLN—Crohn's disease	3.28e-05	0.00235	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—RASGRP1—Crohn's disease	3.25e-05	0.00233	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR9—Crohn's disease	3.23e-05	0.00232	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PLA2G4F—Crohn's disease	3.21e-05	0.00231	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL1B—Crohn's disease	3.15e-05	0.00226	CbGpPWpGaD
Zolmitriptan—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	3.11e-05	0.00223	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	3.09e-05	0.00222	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TAGAP—Crohn's disease	3.06e-05	0.0022	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL3—Crohn's disease	3.05e-05	0.00219	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—GPR65—Crohn's disease	3e-05	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TAGAP—Crohn's disease	3e-05	0.00215	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—RASGRP1—Crohn's disease	2.95e-05	0.00212	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR9—Crohn's disease	2.93e-05	0.0021	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CCR6—Crohn's disease	2.87e-05	0.00206	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CCR6—Crohn's disease	2.81e-05	0.00201	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	2.79e-05	0.00201	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—MTMR3—Crohn's disease	2.73e-05	0.00196	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—GPR65—Crohn's disease	2.72e-05	0.00196	CbGpPWpGaD
Zolmitriptan—HTR1D—G alpha (i) signalling events—CXCL8—Crohn's disease	2.7e-05	0.00194	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	2.68e-05	0.00192	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RSPO3—Crohn's disease	2.68e-05	0.00192	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	2.66e-05	0.00191	CbGpPWpGaD
Zolmitriptan—HTR1B—G alpha (i) signalling events—CXCL8—Crohn's disease	2.64e-05	0.0019	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—ACKR2—Crohn's disease	2.63e-05	0.00189	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RSPO3—Crohn's disease	2.62e-05	0.00188	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CCR6—Crohn's disease	2.6e-05	0.00187	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR ligand binding—CXCL8—Crohn's disease	2.56e-05	0.00183	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CCR6—Crohn's disease	2.55e-05	0.00183	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SEL1L—Crohn's disease	2.54e-05	0.00182	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—PTGER4—Crohn's disease	2.52e-05	0.00181	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—MLN—Crohn's disease	2.5e-05	0.00179	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SEL1L—Crohn's disease	2.48e-05	0.00178	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—PTGER4—Crohn's disease	2.47e-05	0.00177	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CCR6—Crohn's disease	2.4e-05	0.00173	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—IL2RA—Crohn's disease	2.35e-05	0.00169	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR9—Crohn's disease	2.32e-05	0.00167	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—PTGER4—Crohn's disease	2.29e-05	0.00164	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—TNF—Crohn's disease	2.29e-05	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TAGAP—Crohn's disease	2.28e-05	0.00164	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR9—Crohn's disease	2.27e-05	0.00163	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	2.26e-05	0.00162	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—PTGER4—Crohn's disease	2.24e-05	0.00161	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	2.24e-05	0.00161	CbGpPWpGaD
Zolmitriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	2.24e-05	0.00161	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RBX1—Crohn's disease	2.17e-05	0.00156	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—GPR65—Crohn's disease	2.16e-05	0.00155	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL3—Crohn's disease	2.15e-05	0.00154	CbGpPWpGaD
Zolmitriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.15e-05	0.00154	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL2RA—Crohn's disease	2.14e-05	0.00153	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CCR6—Crohn's disease	2.14e-05	0.00153	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—FADS1—Crohn's disease	2.13e-05	0.00153	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—PTGER4—Crohn's disease	2.12e-05	0.00152	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—GPR65—Crohn's disease	2.11e-05	0.00152	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL3—Crohn's disease	2.1e-05	0.00151	CbGpPWpGaD
Zolmitriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	2.1e-05	0.00151	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—RASGRP1—Crohn's disease	2.08e-05	0.00149	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—RASGRP1—Crohn's disease	2.04e-05	0.00146	CbGpPWpGaD
Zolmitriptan—HTR1A—G alpha (i) signalling events—CXCL8—Crohn's disease	2.01e-05	0.00145	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	2e-05	0.00143	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GPX4—Crohn's disease	1.99e-05	0.00143	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL3—Crohn's disease	1.95e-05	0.0014	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	1.95e-05	0.0014	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	1.94e-05	0.00139	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—GCKR—Crohn's disease	1.93e-05	0.00138	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL3—Crohn's disease	1.91e-05	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—UBE2D1—Crohn's disease	1.91e-05	0.00137	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	1.89e-05	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—RASGRP1—Crohn's disease	1.89e-05	0.00136	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	1.88e-05	0.00135	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RIPK2—Crohn's disease	1.85e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—RASGRP1—Crohn's disease	1.85e-05	0.00133	CbGpPWpGaD
Zolmitriptan—MAOA—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.85e-05	0.00133	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL3—Crohn's disease	1.8e-05	0.00129	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	1.76e-05	0.00127	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—RASGRP1—Crohn's disease	1.74e-05	0.00125	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR9—Crohn's disease	1.73e-05	0.00124	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	1.71e-05	0.00123	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	1.65e-05	0.00119	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR ligand binding—CXCL8—Crohn's disease	1.63e-05	0.00117	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—GPR65—Crohn's disease	1.61e-05	0.00116	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	1.6e-05	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	1.6e-05	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR ligand binding—CXCL8—Crohn's disease	1.6e-05	0.00115	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—JAK2—Crohn's disease	1.58e-05	0.00114	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SOCS1—Crohn's disease	1.58e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	1.57e-05	0.00113	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	1.55e-05	0.00111	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CCR6—Crohn's disease	1.54e-05	0.0011	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—TYK2—Crohn's disease	1.51e-05	0.00108	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—IL2RA—Crohn's disease	1.51e-05	0.00108	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CCR6—Crohn's disease	1.51e-05	0.00108	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—IL2RA—Crohn's disease	1.47e-05	0.00106	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL3—Crohn's disease	1.46e-05	0.00105	CbGpPWpGaD
Zolmitriptan—HTR1F—GPCR downstream signaling—CXCL8—Crohn's disease	1.44e-05	0.00104	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—JAK2—Crohn's disease	1.44e-05	0.00103	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	1.41e-05	0.00101	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RBX1—Crohn's disease	1.39e-05	0.000998	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL2RA—Crohn's disease	1.37e-05	0.000982	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—SMAD3—Crohn's disease	1.36e-05	0.000979	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RBX1—Crohn's disease	1.36e-05	0.000977	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—PTGER4—Crohn's disease	1.35e-05	0.000972	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL2RA—Crohn's disease	1.34e-05	0.000961	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—PTGER4—Crohn's disease	1.33e-05	0.000952	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—CXCL8—Crohn's disease	1.31e-05	0.000942	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL2RA—Crohn's disease	1.26e-05	0.000907	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—UBE2D1—Crohn's disease	1.22e-05	0.000875	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	1.22e-05	0.000875	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—UBE2D1—Crohn's disease	1.19e-05	0.000857	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.19e-05	0.000851	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RIPK2—Crohn's disease	1.18e-05	0.000849	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RIPK2—Crohn's disease	1.16e-05	0.000831	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL3—Crohn's disease	1.15e-05	0.000828	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CCR6—Crohn's disease	1.15e-05	0.000823	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL3—Crohn's disease	1.13e-05	0.00081	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	1.12e-05	0.000806	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—RASGRP1—Crohn's disease	1.12e-05	0.000801	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—RASGRP1—Crohn's disease	1.09e-05	0.000784	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RBX1—Crohn's disease	1.04e-05	0.000745	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	1.02e-05	0.000732	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—JAK2—Crohn's disease	1.01e-05	0.000726	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SOCS1—Crohn's disease	1.01e-05	0.000725	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	1.01e-05	0.000725	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—MTMR3—Crohn's disease	1.01e-05	0.000724	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—JAK2—Crohn's disease	9.91e-06	0.000711	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SOCS1—Crohn's disease	9.89e-06	0.00071	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—TYK2—Crohn's disease	9.63e-06	0.000692	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	9.43e-06	0.000677	CbGpPWpGaD
Zolmitriptan—HTR1D—GPCR downstream signaling—CXCL8—Crohn's disease	9.24e-06	0.000663	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—JAK2—Crohn's disease	9.19e-06	0.00066	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	9.09e-06	0.000653	CbGpPWpGaD
Zolmitriptan—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	9.04e-06	0.000649	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	9e-06	0.000646	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—TYK2—Crohn's disease	8.9e-06	0.000639	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	8.82e-06	0.000633	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—SMAD3—Crohn's disease	8.72e-06	0.000626	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL3—Crohn's disease	8.6e-06	0.000617	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	8.54e-06	0.000613	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—JAK2—Crohn's disease	8.49e-06	0.000609	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—CXCL8—Crohn's disease	8.39e-06	0.000602	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	8.32e-06	0.000597	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	8.21e-06	0.00059	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL2RA—Crohn's disease	8.08e-06	0.00058	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	7.91e-06	0.000568	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—FADS1—Crohn's disease	7.85e-06	0.000564	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—CXCL8—Crohn's disease	7.75e-06	0.000556	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	7.55e-06	0.000542	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	7.54e-06	0.000541	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling by GPCR—IL6—Crohn's disease	7.37e-06	0.000529	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GPX4—Crohn's disease	7.35e-06	0.000528	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	7.19e-06	0.000516	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—GCKR—Crohn's disease	7.1e-06	0.00051	CbGpPWpGaD
Zolmitriptan—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	6.89e-06	0.000495	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	6.85e-06	0.000492	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	6.51e-06	0.000467	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	6.26e-06	0.000449	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—STAT3—Crohn's disease	6.23e-06	0.000447	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—ALB—Crohn's disease	6.13e-06	0.00044	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	6.02e-06	0.000432	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—TYK2—Crohn's disease	5.69e-06	0.000409	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—TYK2—Crohn's disease	5.57e-06	0.0004	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—JAK2—Crohn's disease	5.43e-06	0.00039	CbGpPWpGaD
Zolmitriptan—MAOA—Metabolism—PTGS2—Crohn's disease	5.36e-06	0.000385	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—JAK2—Crohn's disease	5.32e-06	0.000382	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.07e-06	0.000364	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—CXCL8—Crohn's disease	4.95e-06	0.000356	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	4.85e-06	0.000348	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling by GPCR—IL6—Crohn's disease	4.71e-06	0.000338	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling by GPCR—IL6—Crohn's disease	4.61e-06	0.000331	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.44e-06	0.000319	CbGpPWpGaD
Zolmitriptan—HTR1F—Signaling Pathways—IL6—Crohn's disease	4.35e-06	0.000312	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—TYK2—Crohn's disease	4.24e-06	0.000305	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—JAK2—Crohn's disease	4.05e-06	0.000291	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—STAT3—Crohn's disease	3.98e-06	0.000286	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—STAT3—Crohn's disease	3.9e-06	0.00028	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.7e-06	0.000265	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling by GPCR—IL6—Crohn's disease	3.51e-06	0.000252	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.97e-06	0.000213	CbGpPWpGaD
Zolmitriptan—HTR1D—Signaling Pathways—IL6—Crohn's disease	2.78e-06	0.0002	CbGpPWpGaD
Zolmitriptan—HTR1B—Signaling Pathways—IL6—Crohn's disease	2.73e-06	0.000196	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—ALB—Crohn's disease	2.26e-06	0.000162	CbGpPWpGaD
Zolmitriptan—HTR1A—Signaling Pathways—IL6—Crohn's disease	2.08e-06	0.000149	CbGpPWpGaD
Zolmitriptan—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.98e-06	0.000142	CbGpPWpGaD
